Navigation Links
Cardium Receives Preliminary Notification of Inclusion in the Russell 3000(R) Index and Russell Global(R) Index
Date:6/17/2009

in the Russell 3000 Index and Russell Global Index will broaden our investor exposure, or otherwise benefit Cardium or its stock, that our products and product candidates will be successfully advanced and will prove to be sufficiently safe and effective, or that our products or product candidates will not be unfavorably compared to competitive products that may be regarded as safer, more effective, easier to use or less expensive. Actual results may also differ substantially from those described in or contemplated by this press release due to risks and uncertainties that exist in our operations and business environment, including, without limitation, risks and uncertainties that are inherent in the development of complex biologics and therapeutic hypothermia devices and in the conduct of human clinical trials, including the timing, costs and outcomes of such trials, our ability to obtain necessary funding, regulatory approvals and expected qualifications, our dependence upon proprietary technology, our history of operating losses and accumulated deficits, our reliance on collaborative relationships and critical personnel, and current and future competition, as well as other risks described from time to time in filings we make with the Securities and Exchange Commission. We undertake no obligation to release publicly the results of any revisions to these forward-looking statements to reflect events or circumstances arising after the date hereof.

Copyright 2009 Cardium Therapeutics, Inc. All rights reserved.

For Terms of Use Privacy Policy, please visit www.cardiumthx.com.

Cardium Therapeutics(TM) and Generx(R) are trademarks of Cardium Therapeutics, Inc.

Tissue Repair(TM), Gene Activated Matrix(TM), GAM(TM), and Excellarate(TM)

are trademarks of Tissue Repair Company.

InnerCool Therapies(R), In
'/>"/>

SOURCE Cardium Therapeutics
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Cardium Presents Gene Activated Matrix Technology and Update on Excellarate Clinical Development Program at ASGT Annual Meeting
2. Cardium Reports on First Quarter 2009 Financial Results and Recent Developments
3. Cardium Reports on New Excellarate(TM) Product Formulations to Expand Commercialization Potential Into Multiple Wound Healing Applications
4. Cardium Provides Update Regarding Exchange Listing Compliance Plan Accepted by NYSE Amex
5. Cardiums InnerCool Announces Journal of Neurotrauma Highlights Hypothermia Therapys Role in Post Cardiac Arrest, and Traumatic Brain and Spinal Cord Injury Patients
6. Cardium Reports on Recent Highlights, Financial Results and 2009 Outlook
7. Cardiums Exchange Listing Compliance Plan Accepted by NYSE Alternext US
8. Cardiums InnerCool Reports on Expanding Use of Therapeutic Hypothermia
9. Cardiums InnerCool Announces Launch of New Enhanced Website
10. Cardium Reports on Exchange Listing With NYSE Alternext US
11. Cardium Reports on New York Citys Adoption of Therapeutic Cooling Protocols for Cardiac Arrest Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... Savannah, GA (PRWEB) September 23, 2014 ... local community through philanthropic support. Most recently, the gym ... through their Ageless Fitness program. Throughout the year, World ... for many other charitable causes. , Over the summer, ... Meals on Wheels. Through their Ageless Fitness program, participants ...
(Date:9/23/2014)... Kathleen Doheny HealthDay Reporter ... at very low birth weights, breast milk is more likely ... infection known as cytomegalovirus (CMV), a new study finds. ... infants -- all of whom weighed 3.3 pounds or less ... of CMV infection, to see whether breast milk or transfusions ...
(Date:9/23/2014)... Avid collector Andrew Hawley, from Vintage Rock Posters, ... Seattle concert posters. The Doors were a smash hit after ... The Seattle Eagles Auditorium concert was held on July 23. ... Eagles Auditorium in November the same year. The artist that ... in three colors. The poster is a split fountain silkscreen ...
(Date:9/23/2014)... 2014 (HealthDay News) -- The number of ,rogue, ... is growing, so doctors need to be vigilant ... Administration warned Tuesday. In a statement, the ... it has launched a program to educate doctors ... proper drug purchasing procedures. The program aims to ...
(Date:9/23/2014)... Vancouver, BC (PRWEB) September 23, 2014 ... it will now be offering commercial electrical services in ... scales of operations; whether it is a small maintenance ... will personalize its solution package to meet the needs ... announced that the services will be of an affordable ...
Breaking Medicine News(10 mins):Health News:World of Home Fitness Supports Meals on Wheels 2Health News:Breast Milk a Risk for Spreading Common Virus to Preemies, Study Finds 2Health News:Breast Milk a Risk for Spreading Common Virus to Preemies, Study Finds 3Health News:Pro Ace Now Offers Commercial Electrical Services in Vancouver 2
... According to researchers at Purdue University and the Centers for ... the spread of bird flu in human beings. ,Purdue ... immunity against avian influenza viruses, or bird flu, the most ... in humans. The researchers are focusing on using a harmless ...
... and Colleagues has reported the dosage difference which is ... risk of thyroid cancer. ,The study was ... thyroid cancer during their childhood. The thyroid gland which ... thyroid cancer and there seems to be a relationship ...
... had shown that for obese employees, employers incur an ... with such employees. ,The findings, which appear in ... of Health Promotion, show that for men employed full ... capita cost of being obese, including medical expenses and ...
... everywhere. Atherosclerosis is a big problem and health hazard ... yet another study. ,The study states that supplementation ... // (plaque build-up on the blood vessel walls)., ... homocysteine in the blood. The current study was intended ...
... Researchers from National Cancer Institute has tested the efficacy ... and Anti-androgen hormone therapy to Prostate cancer patients ... no metastatic disease. The Phase II trial was conducted ... but having high Prostate Specific Antigen (PSA) values. The ...
... to handle. Even when so much has been done to ... always been a problem. Viral infections are difficult to ... has always been potent enough to escape even the newer ... as it is called has been posing a challenge for ...
Cached Medicine News:Health News:Risk of Thyroid cancer is increased after Childhood Irradiation of Neck region 2Health News:Combination Therapy To Avoid Prostate Cancer Recurrence 2
(Date:9/23/2014)... This test can detect HIV infection if used ... by activities that can transfer body fluids from one person ... shared needles. , An in-vitro diagnostic home-use test ... test works by looking for your body,s response to fighting ... enabling patients to learn their status in a single visit ...
(Date:9/23/2014)... Research and Markets has announced the addition ... report to their offering. Though biotechnology ... products to treat cancer, diabetes, HIV/AIDS and autoimmune disorders ... stages of clinical drug testing for new biopharmaceuticals, as ... to upscale while anticipating FDA or EMA approval. During ...
(Date:9/23/2014)... FRANCISCO , Sept. 23, 2014  SiteOne Therapeutics ... of equity financing. Led by Sears Capital Management and ... Joe Zakrzewski , the $1.5 million financing positions ... program for pain and to further develop its technology ... pain indications. In conjunction with the financing, ...
Breaking Medicine Technology:WholeHealth Products announces the release of the FDA Cleared "HIV 1&2" Rapid Diagnostic Test for Professional and Retail 2Biopharmaceutical and Vaccine Production Markets 2Biopharmaceutical and Vaccine Production Markets 3SiteOne Therapeutics Completes $1.5M Initial Round of Equity Financing, Secures $1.4M NIH Grant 2SiteOne Therapeutics Completes $1.5M Initial Round of Equity Financing, Secures $1.4M NIH Grant 3
... HeartSine Technologies, Inc. was honored with the ... 50 event in Stormont, Belfast. The award was presented to ... pioneering business in developing areas of Belfast, Ireland. ... the Long Gallery in Stormont on behalf of HeartSine, said, ...
... N.Y., Oct. 11 Dr. Joan Fallon, founder and CEO ... research and development company focused on the treatment of neurological ... Life Sciences Summit 2010, held September 22-23 in Hauppauge, New ... New York at Stony Brook, Brookhaven National Laboratories and Cold ...
Cached Medicine Technology:HeartSine Technologies Honored With Belfast Ambassador Award at Belfast Business Top 50 Event 2Curemark Moderates Autism Panel at Life Sciences Summit 2010 2Curemark Moderates Autism Panel at Life Sciences Summit 2010 3
... ALLEGRO Topolyzer and T-CAT have been optimized ... vision correction and to interact in perfect ... systems. All necessary treatment and patient parameters ... the ALLEGRETTO WAVE laser systems via diskette, ...
RESTASIS® (cyclosporine ophthalmic emulsion) 0.05% is the first and only therapy for patients with keratoconjunctivitis sicca (Dry Eye Disease) whose tear production is presumed to be supressed d...
ZYMAR™ ophthalmic solution is an anti-infective prescription eye drop that your doctor may instruct you to use if you have an eye infection caused by bacteria. Bacterial conjunctivitis is the e...
... P.M.® lets you sleep on ... in the morning awake with ... ready to take on the ... comfort and protection, this preservative-free ...
Medicine Products: